Sobre 3 señales de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Historial de señales
Discover the complete record of transactions filed by Hawkins Richard J, Presidente y Director General. Director active across 5 companies, notably Savara Inc. Cumulatively, 21 reports have been published. Breakdown: 7 buys · 0 sell. Total volume traded: €134k. Activity tracked since 13 December 2021. The latest transaction was disclosed on 9 December 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Hawkins Richard J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
728 títulos@ 0,55 US$0.4% de su flujoCommon StockSEC:0001209191-21-069582:0
21 de 21 declaraciones
About Hawkins Richard J
Président-Directeur Général, Hawkins Richard J has filed 21 disclosures. In the recent filings tracked, they cover the period from 2021-12-14 to 2025-12-11, with EUR 133539 of purchases and EUR 0 of sales. They are also Chief Executive Officer of Lumos Pharma, INC., as well as Director of Savara Inc and Plus Therapeutics, INC.